Pharmacists in Selma, TX Accepting Medicare
8 Pharmacists found. Showing 1 - 8
 Jennifer Ashley, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8234 Agora Pkwy, Selma, TX 78154 Phone: 210-945-9759 |
 Dr. Yangda Pan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15810 Cardinal Pt, Selma, TX 78154 Phone: 512-431-2836 |
Robert Nichael Dobbins, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15330 Ih 35 N, Selma, TX 78154 Phone: 210-332-1081 |
Dr. Tara Howard, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15330 Ih 35 N, Selma, TX 78154 Phone: 210-332-1081 |
Hiram Mojica, BS Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8234 Agora Pkwy, Selma, TX 78154 Phone: 210-945-9759 Fax: 210-945-9759 |
Ofelia Sylvia Moorman, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15330 Ih 35 N, Selma, TX 78154 Phone: 210-332-1081 |
Geethu Philix Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8234 Agora Pkwy, Selma, TX 78154 Phone: 210-945-9759 |
Thomas Leo Hamilton, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15330 Ih 35 N, Selma, TX 78154 Phone: 210-332-1081 |
News Archive
New article provides guidance on managing critically ill patients at risk for alcohol withdrawal
Alcohol withdrawal adds challenges to caring for critically ill patients, and nurses must be diligent at each stage of care to minimize complications, according to an article in the February issue of Critical Care Nurse.
Kylin receives $250,000 IRS award to advance pRNAi nanoparticle cancer treatment research
Officials of Kylin Therapeutics Inc. announces that they received a therapeutic discovery project grant from the U.S. Internal Revenue Service that will advance the company's pRNAi nanoparticle cancer treatment research.
Plasma zinc status not an effective prognostic factor for hospitalized COVID-19 patients
Due to previous evidence suggesting that zinc deficiencies can lead to complications along with an impaired antiviral response, a group of international researchers has undertaken a prospective observational study to investigate this association further.
Novel GammaPod system receives FDA clearance to treat early stage breast cancer
The GammaPod - a first-of-its kind stereotactic radiotherapy system to treat early stage breast cancer - has received 510(k) clearance from the U.S. Food and Drug Administration, paving the way for the manufacturer to bring the system to market for the treatment of breast cancer patients.
Telesta closes US$28.6 million in private placement financing
Telesta Therapeutics Inc. announced today that it has closed a private placement financing of US$28.6 million. This transaction was led by several prominent U.S. healthcare investors, including Consonance Capital Investors, Boxer Capital of Tavistock Life Sciences and Omega Funds. In addition, certain members of the senior management team and board of directors of Telesta participated in the transaction.
› Verified 2 days ago
Pharmacists
Counselors
Clinical Social Workers
Occupational Therapists